Every material Form 8-K CTS has filed with the SEC since September 10, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CTS Corporation furnished an October 2026 investor presentation under Regulation FD. It shows third-quarter 2026 net sales of $149.6 million, up from $143.0 million a year earlier, and GAAP diluted EPS of $0.61 versus $0.46. The deck also gives updated fiscal 2026 guidance of $580 million to $590 million in revenue and $2.78 to $2.88 in adjusted diluted EPS, with the Millar acquisition included.
Q3 2026 net sales were $149.6 million, compared with $143.0 million in Q3 2025.
Q3 2026 net earnings were $17.8 million, or $0.61 per diluted share, compared with $13.7 million, or $0.46, a year earlier; adjusted diluted EPS was $0.77 versus $0.60.
Updated FY 2026 guidance: revenue of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88, including the expected impact of the Millar acquisition.
Q3 2026 results include a $12.5 million pretax insurance recovery, which the company excludes from adjusted figures.
CTS reported third-quarter 2026 sales of $149.6 million, up 5% from a year earlier, and diluted EPS of $0.61 versus $0.46. It raised its 2026 guidance, lifting the sales range to $580-$590 million from $565-$585 million and the adjusted diluted EPS range to $2.78-$2.88 from $2.55-$2.70. Reported third-quarter results include a $12.5 million insurance recovery that the company excludes from its adjusted figures.
Q3 2026 sales were $149.6 million, up 5%; diluted EPS was $0.61 versus $0.46, and adjusted diluted EPS was $0.77 versus $0.60.
2026 sales guidance raised to $580-$590 million from $565-$585 million.
2026 adjusted diluted EPS guidance raised to $2.78-$2.88 from $2.55-$2.70.
Q3 2026 results include a $12.5 million insurance recovery, which the company excludes from adjusted EBITDA and adjusted EPS.
CTS reported second-quarter 2026 sales of $144.8 million, up 7% from a year earlier, with net earnings of $19.2 million and diluted EPS of $0.66, compared with $18.5 million and $0.62 in the second quarter of 2025. The company raised its 2026 guidance, lifting its sales outlook to $565 million to $585 million and its adjusted diluted EPS outlook to $2.55 to $2.70. Transportation sales declined 2%, while sales to diversified end markets rose 15%.
Sales were $144.8 million, up 7%; diversified end-market sales rose 15% and transportation sales fell 2%.
Net earnings were $19.2 million, or $0.66 per diluted share, versus $18.5 million, or $0.62, a year earlier.
Adjusted diluted EPS was $0.74, up from $0.57; adjusted EBITDA margin was 25.4%, up from 23.0%.
2026 guidance raised: sales to $565 million to $585 million (from $560 million to $580 million); adjusted diluted EPS to $2.55 to $2.70 (from $2.35 to $2.45).
CTS Corporation said its President and CEO, Kieran O'Sullivan, will step down effective July 6, 2026, and remain on the Board as Executive Chairman. The Board appointed Chief Operating Officer Pratik Trivedi as President and CEO on the same date, and expanded the Board from eight to nine directors.
Kieran O'Sullivan steps down as CEO effective July 6, 2026, and becomes Executive Chairman with a $625,000 base salary.
Pratik Trivedi, 47, becomes President and CEO with a $675,000 base salary and a 100% target annual cash incentive.
Trivedi's new long-term incentive award has a value of $2,150,000, split 60% performance-based and 40% service-based restricted stock units.
O'Sullivan will receive no new long-term incentive award; the Board increases from eight to nine directors.
CTS reported first-quarter 2026 sales of $139.2 million, up 11% from a year earlier, with net income of $17.2 million and diluted EPS of $0.59 versus $0.44. The company narrowed its 2026 guidance, raising the low end of its sales range to $560 million-$580 million and of its adjusted diluted EPS range to $2.35-$2.45, which points to stronger expected results for shareholders.
Q1 2026 sales $139.2 million, up 11% year over year; diversified end-market sales up 18%, transportation up 3%
Diluted EPS $0.59 versus $0.44 a year earlier; adjusted diluted EPS $0.62 versus $0.44
2026 sales guidance narrowed to $560 million-$580 million from $550 million-$580 million
2026 adjusted diluted EPS guidance narrowed to $2.35-$2.45 from $2.30-$2.45, assuming current market conditions continue
CTS reported fourth-quarter and full-year 2025 results on February 10, 2026, with sales and profit both higher than in 2024. The company also gave 2026 guidance of $550 million to $580 million in sales and adjusted diluted EPS of $2.30 to $2.45, which gives shareholders a current outlook for the year ahead.
Q4 2025 sales were $137 million, up 9% year over year; diversified end markets rose 16% while transportation fell 1%
Q4 2025 diluted EPS was $0.67 versus $0.38; adjusted diluted EPS was $0.62 versus $0.50
Full-year 2025 sales were $541 million, up 5%; diluted EPS was $2.19 versus $1.80, and adjusted diluted EPS was $2.23 versus $2.12
2026 guidance: sales of $550 million to $580 million and adjusted diluted EPS of $2.30 to $2.45
CTS Corporation said Senior Vice President Martin Baumeister resigned effective December 5, 2025, to pursue another opportunity, and Senior Vice President Pratik Trivedi was appointed chief operating officer effective the same date. The filing says the resignation was not due to any disagreement with CTS and that no material new compensation or equity was granted to Trivedi for the role, so the change is a leadership transition with no stated financial terms.
Martin Baumeister resigned as Senior Vice President, effective close of business December 5, 2025; notice given November 21, 2025
Pratik Trivedi, 46, appointed chief operating officer effective December 5, 2025
Trivedi joined CTS in April 2024; previously VP, North America, mobility business at Eaton Corporation plc
CTS states no material contract, compensation change or equity grant was made in connection with the COO appointment
CTS Corporation entered a five-year, $300 million unsecured revolving credit agreement with Wells Fargo as administrative agent, terminating its prior $400 million facility. Proceeds from initial borrowings repaid $63.3 million owed under the prior agreement, and the filing describes covenants requiring a net leverage ratio of no more than 3.5 to 1.0 and an interest coverage ratio of at least 3.0 to 1.
New five-year unsecured revolving credit facility of $300 million, dated November 24, 2025
Replaces the prior $400 million unsecured credit facility, which was terminated as of November 24, 2025
Initial borrowings used to repay $63.3 million outstanding under the prior agreement
Covenants include a maximum net leverage ratio of 3.5 to 1.0 and a minimum interest coverage ratio of 3.0 to 1
CTS Corporation increased its board from seven to eight members and elected Kimberly MacKay to fill the new seat, effective November 5, 2025. MacKay is SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc., and will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee.
Board size increased from seven to eight members effective November 5, 2025
Kimberly MacKay is SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc.
MacKay will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee
The company will enter into an indemnification agreement with MacKay
CTS Corporation reported third quarter 2025 sales of $143 million, up 8% from a year earlier, with sales to diversified end markets up 22%. Net income fell to $14 million, or $0.46 per diluted share, from $18 million, or $0.59, and included a $4.2 million charge tied to an EPA past cost recovery claim. The company updated its 2025 guidance to sales of $535 million to $545 million and adjusted diluted EPS of $2.20 to $2.25.
Sales were $143 million, up 8%; transportation sales fell 7% and diversified end market sales rose 22%.
Net income was $14 million, or $0.46 per diluted share, versus $18 million, or $0.59, a year earlier.
Adjusted diluted EPS was $0.60, versus $0.61 a year earlier, including a $0.03 unfavorable impact from recent US tax legislation.
Updated 2025 guidance: sales of $535 million to $545 million and adjusted diluted EPS of $2.20 to $2.25.
CTS reported second-quarter 2025 sales of $135 million, up 4% from a year earlier, and diluted EPS of $0.62, up from $0.48. The company maintained its 2025 guidance of $520-$550 million in sales and adjusted diluted EPS of $2.20-$2.35, which signals no change to its outlook.
Sales were $135 million, up 4%; diversified end markets rose 13% while transportation fell 6%
Diluted EPS was $0.62 vs $0.48; adjusted diluted EPS was $0.57 vs $0.54
2025 guidance maintained: sales of $520-$550 million and adjusted diluted EPS of $2.20-$2.35
Operating cash flow was $28 million vs $20 million a year earlier
CTS Corporation appointed Mark Pacioni as Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025. He previously served as Chief Legal Officer and Secretary of CareerBuilder + Monster, and his compensation package includes a $375,000 base salary and a 55% target incentive opportunity.
Appointed effective July 1, 2025, with the company announcing it by press release the same day
Base salary of $375,000 and target management incentive of 55% of base salary
Equity grants of 4,600 time-based RSUs vesting over three years and 7,000 performance-based RSUs tied to financial objectives over three years
Prior role: Chief Legal Officer and Secretary of CareerBuilder + Monster, April 2019 to June 2025
CTS reported first quarter 2025 results, with sales flat year over year at $126 million. Diversified end-market sales rose 14%, while transportation sales fell 12%, and GAAP diluted EPS rose to $0.44 from $0.36, but adjusted diluted EPS fell to $0.44 from $0.47. The company kept its 2025 guidance of $520 million to $550 million in sales and $2.20 to $2.35 in adjusted diluted EPS.
Sales were $126 million, flat year over year; diversified end-market sales rose 14% and transportation sales fell 12%.
GAAP diluted EPS was $0.44 versus $0.36 a year earlier; adjusted diluted EPS was $0.44 versus $0.47.
Operating cash flow was $16 million, compared with $18 million in the first quarter of 2024.
2025 guidance was maintained: sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35.
CTS Corporation disclosed that Scott D'Angelo, its Vice President, Chief Legal and Administrative Officer and Corporate Secretary, resigned on March 5, 2025, effective April 4, 2025. The company said the departure was a personal decision to pursue another chief legal officer opportunity and was not the result of any disagreement with the company.
Scott D'Angelo submitted his resignation on March 5, 2025, effective April 4, 2025.
He holds the roles of Vice President, Chief Legal and Administrative Officer and Corporate Secretary.
He will remain in these roles until the effective date.
The filing states the resignation was not the result of any disagreement with the company.
CTS Corporation reported fourth-quarter and full-year 2024 results on February 4, 2025. Q4 sales rose 2% to $127 million, but GAAP diluted EPS fell to $0.45 from $0.49, while adjusted diluted EPS rose to $0.53 from $0.47. For 2025, the company expects sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35, compared with 2024 adjusted EPS of $2.17.
Q4 2024 sales were $127 million, up 2% year over year; the SyQwest acquisition added $11 million.
Full-year 2024 sales were $516 million, down 6%; full-year diluted EPS was $1.89 versus $1.92 in 2023.
Full-year 2024 operating cash flow was $99 million, up from $89 million in 2023.
2025 guidance: sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35.
CTS reported third-quarter 2024 sales of $132 million, down 2% from a year earlier, while net income rose to $19 million from $14 million and diluted EPS reached $0.61 versus $0.44. The company lowered its full-year 2024 sales guidance to $515 million-$525 million from $525 million-$540 million, but kept its adjusted diluted EPS guidance of $2.05-$2.25, so shareholders face weaker revenue expectations even as profitability improved.
Q3 2024 sales were $132 million, down 2% year over year, and net income was $19 million, or 14% of sales.
Diluted EPS was $0.61 versus $0.44 a year earlier; adjusted diluted EPS was $0.63 versus $0.54.
Full-year 2024 sales guidance was cut to $515 million-$525 million from $525 million-$540 million.
Adjusted diluted EPS guidance of $2.05-$2.25 was reiterated; operating cash flow rose to $35 million from $22 million.
CTS Corporation said its principal accounting officer, Thomas White, is resigning to pursue a new professional opportunity, effective September 18, 2024. The filing says the departure is not related to any disagreement with auditors or management on accounting, disclosure, or internal controls, and that CFO Ashish Agrawal will take on the principal accounting officer role.
Thomas White notified the company of his resignation on September 4, 2024, effective September 18, 2024
Reason given: to pursue a new professional opportunity
No disagreement with auditors or management on accounting principles, financial statement disclosure, or internal controls, per the filing
Vice President and CFO Ashish Agrawal will act as principal accounting officer upon White's departure
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CTS filing is on SEC EDGAR ↗. 8-K briefs of other companies →